论文部分内容阅读
慢性粒细胞白血病(ＣＭＬ)的Ｐｈ+细胞输入量多少与自体外周血造血干细胞(ＰＢＳＣ)移植的预后相关,因此可用化疗对ＰＢＳＣ进行Ｐｈ的体内净化。病人和方法 Ｐｈ+ＣＭＬ患者57例,其中44例为首发慢性期(ＣＰ1),13例为加速期或急变期。动员方案采用以下4种:①“5+2”:阿糖胞苷1
The amount of Ph+ cell input in chronic myelogenous leukemia (CML) is related to the prognosis of autologous peripheral blood stem cell (PBSC) transplantation, so Ph in vivo purification of PBSC by chemotherapy can be performed. Patients and Methods 57 patients with Ph+CML, of whom 44 were in the first chronic phase (CP1) and 13 were in accelerated or blast crisis. The following four kinds of mobilization programs are used: 1 “5+2”: cytarabine 1